leisure time -WSS

leisure time

author：fashion 2025-09-27 09:38:18 - browse：16913

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： JPM 2024: Verve Therapeutics looks to mainstream genome editing

focus

WSS

New menopause drug shows promise in relief for hot flashes

Readout Newsletter: Merck, Vertex, and Viking updates

Doulas covered by Medicaid under New York's new plan

Readout Newsletter: Merck, Vertex, and Viking updates

Fauci’s Covid grilling leads GOP to weigh foreign research rules

States should stop sabotaging methadone treatment reform

Wikipedia

leisure time

knowledge

New air purifier tech could be key to improving indoor air quality

How I ended up pumping milk in a bathroom stall at JPM 2024

Activists slam private health insurers over coverage restrictions

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: mifepristone case, GLP

Heart attack and stroke risk calculators need revising

Vertex Pharmaceuticals may move headquarters in Boston

After affirmative action ruling, medical educators look to 'holistic review'

There's no autism epidemic. It's an autism diagnosis epidemic

explore

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Risky weight loss products often used by teens globally, per study

Patient advocates debate FDA's accelerated approval process

Will generative AI in health care meet the fate of IBM's Dr. Watson?

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Abortion pill Supreme Court ruling could impact entire drug industry

focus

focus

focus

entertainment